Arcus Biosciences Provides Update on Clinical Programs, Including Key 2022 Milestones

Go back to Arcus Biosciences Provides Update on Clinical Programs, Including Key 2022 Milestones
(NYSE: RCUS) Delayed: 24.31 +0.19 (0.79%)
Previous Close $24.12    52 Week High
Open $24.50    52 Week Low
Day High $24.84    P/E N/A 
Day Low $23.80    EPS
Volume 2,309,066